As climate change accelerates, it is becoming increasingly important to study the impact of climate change on human health.
Vicore sells rights to IPF drug in Japan; Roche to lay off 340 workers; Sensorion’s €50M offering
Plus, news about Tenaya Therapeutics, Adverum Biotechnologies, YS Biopharma, Evoke Pharma and BioXcel Therapeutics: Nippon Shinyaku gets rights in Japan to IPF drug: The Japanese